You are here

Cancer Informatics

Cancer Informatics


eISSN: 11769351 | ISSN: 11769351 | Current volume: 22 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Indexed using PubMed Central (PMC), ESCI, Scopus, and DOAJ
  • Published since 2008
  • Publication is subject to payment of an article processing charge (APC)

Cancer Informatics is an open access, peer reviewed, international journal that focuses on reporting bioinformatics analyses of molecular genetics and/or clinical data pertaining to human cancer risk, prevention, outcome, or treatment response. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).


Submission Information

Submit your manuscript here.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for this journal is currently $2800 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to CIX@sagepub.com

The field of cancer research relies on advances in many other disciplines, including omics technology, mass spectrometry, radio imaging, computer science, and biostatistics. Cancer Informatics provides open access to peer-reviewed high-quality manuscripts reporting bioinformatics analysis of molecular genetics and/or clinical data pertaining to cancer, emphasizing the use of machine learning, artificial intelligence, statistical algorithms, advanced imaging techniques, data visualization, and high-throughput technologies. As the leading journal dedicated exclusively to the report of the use of computational methods in cancer research and practice, Cancer Informatics leverages methodological improvements in systems biology, genomics, proteomics, metabolomics, and molecular biochemistry into the fields of cancer detection, treatment, classification, risk-prediction, prevention, outcome, and modeling.

Our goal is to publish sound science. This means we look for research that adheres to ethical standards, uses robust methodologies that are transparent and reproducible, and uses appropriate statistical analyses to ensure clear, credible, and trustworthy results. We care more about the quality and reliability of the contribution an article makes than we do the size of that contribution. Cancer Informatics evaluates manuscripts based on how the research was conducted and reported.

Manuscript Submission

  • Submit your manuscript here.
  • Please refer to the Submission Guidelines tab for more information before submitting your manuscript.

Editor in Chief
J.T. Efird VA - Cooperative Studies Program Coordinating Center, Boston, MA, USA, & Case Western Reserve University School School of Medicine, Cleveland, OH, USA
Managing Editor
Lingling Tian SAGE Publishing, Shanghai, China
Editorial Board
Hoda Anton-Culver University of California, Irvine, USA
Michael J. Becich University of Pittsburgh, USA
Idriss M. Bennani-Baiti Cancer Epigenetics Society, Austria
Silvio Bicciato University of Padova, Padova, Italy
Serdar Bozdag University of North Texas, USA
Benedikt Brors German Cancer Research Center, Germany
Enrico Capobianco National Research Council of Italy, Italy
Arul M. Chinnaiyan University of Michigan, USA
William Cho !Queen Elizabeth Hospital, Hong Kong
Robert Clarke Hormel Institute at the University of Minnesota
Robert C. Cockrell University of Vermont, USA
Kevin Coombes Augusta University, United States
Roger Day University of Pittsburgh, USA
Thomas S. Deisboeck Massachusetts General Hospital, USA
Eytan Domany Weizmann Institute of Science, Israel
Edward R. Dougherty Texas A&M University, USA
Ziding Feng Fred Hutchinson Cancer Research Center, USA
David J. Foran Rutgers Cancer Institute of New Jersey, USA
Kai Fu UCLA, USA
Debashis Ghosh The University of Colorado Anschutz Medical Campus, USA
Judith D. Goldberg New York University School of Medicine, USA
Alex Graudenzi University of Milano-Bicocca, Italy
William Grizzle University of Alabama at Birmingham, Birmingham, Alabama, USA
Jack K. Horner JKH Consulting, USA
Grant Izmirlian National Cancer Institute, USA
Sarath C. Janga Indiana University - Purdue University, USA
Igor Jurisica University of Toronto, Canada
R. Krishna Murthy Karuturi The Jackson Laboratory, USA
Meik Kunz Universität Erlangen–Nürnberg, Germany
Eva K. Lee Georgia Institute of Technology, USA
Lang Li Ohio State University, USA
Jack W. London Thomas Jefferson University, USA
Mia Markey University of Texas at Austin, USA
Gary M. Marsh University of Pittsburgh, USA
Geoff McLachlan University of Queensland, Australia
Jill P Mesirov University of California, San Diego, USA
Michael Ochs Fox Chase Cancer Center, USA
Elissa M. Ozanne University of California, San Francisco, USA
Taesung Park Seoul National University, South Korea
Paul Martin Putora Kantonsspital St. Gallen and University of Bern, Switzerland
Kun Qu University of Science and Technology, China
Joel Saltz Stony Brook School of Medicine, NY, USA
Ravi Sankar University of South Florida, USA
Roland Schwarz Berlin Institute for Medical Systems Biology, Germany
Simon Sherman University of Nebraska Medical Center, USA
Sudhir Srivastava National Institutes of Health, USA
George S. Stamatakos National Technical University of Athens, Greece
David J. States Affigen
Mahlet Tadesse Georgetown University, USA
Aik Choon Tan University of Utah, United States
Evangelos Triantaphyllou Louisiana State University and Tulane University, USA
Alex Tsodikov University of Michigan, USA
William J. Welsh Rutgers University, USA
James Willey University of Toledo Health Sciences Campus, Toledo, Ohio, USA
Ka-Chun Wong City University of Hong Kong, Hong Kong
Lianbo Yu The Ohio State University, USA
Editorial Review Board
Syed Thouheed Ahmed REVA University, India
Jaine Katharine Blayney Queen's University of Belfast, United Kingdom
Monica Butnariu University of Life Sciences "King Mihai I" from Timisoara, Romania
Xueyuan Cao University of Tennessee Health Science Center, USA
Gerardo Cazzato University of Bari Aldo Moro, Italy
Jan Christopher Cwik University of Cologne, Germany
Syed Muhammad Yousaf Farooq The University of Lahore, Pakistan
Varun Gupta National Institute of Technology Sikkim, India
Simona Gurzu George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu-Mures, Romania
Yuriy Gusev Georgetown University, USA
Junjie Ma Amgen Inc, USA
Eleftherios Makris University of Pittsburgh, USA
Georgina Menzies Cardiff University, United Kingdom
Mansoor-Ali Vaali- Mohammed King Saud University, Saudi Arabia
Mogeeb A. A. Mosleh Taiz University, Yemen
Indraneil Mukherjee Staten Island University Hospital, USA
Wafaa Mohamed ElAnor Ahmed Rashed CCHE-57357, Egypt
Leszek Siwik AGH University of Science and Technology, Poland
Arunima Srivastava The Ohio State University, USA
Suchitra Sundaram Mount Sinai Icahn School of Medicine, USA
Daniele Ugo Tari Caserta Local Health Authority, Italy
Suyan Tian Jilin University, China
Hardeep Singh Tuli Maharishi Markandeshwar University, India
Ziheng Wang University of Macau, MSAR
Justin M. Wozniak Argonne National Laboratory, USA
Pratheepan Yogarajah Ulster University, United Kingdom
Yuping Zhang University of Michigan, USA
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.